Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study. Feb 2010 - Int J Hyperthermia; 26(2):1464-5157 [PMID:20146566] [Fotopoulou C] [Hee Cho C] [Kraetschell R] [Gellermann J] [Wust P] [Lichtenegger W] [Sehouli J]
Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum. Feb 2010 - Int J Hyperthermia; 26(2):1464-5157 [PMID:20146565] [Maluta S] [Romano M] [Dall'oglio S] [Genna M] [Oliani C] [Pioli F] [Gabbani M] [Marciai N] [Palazzi M]
Ovarian cancer immunotherapy: opportunities, progresses and challenges. Feb 2010 - ; 3(1):1756-8722 [PMID:20146807] [Liu B] [Nash J] [Runowicz C] [Swede H] [Stevens R] [Li Z]
Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28. Feb 2010 - :1537-4513 [PMID:20145548] [Rosenblatt J] [Wu Z] [Vasir B] [Zarwan C] [Stone R] [Mills H] [Friedman T] [Konstantinopoulos PA] [Spentzos D] [Ghebremichael M] [Stevenson K] [Neuberg D] [Levine JD] [Joyce R] [Tzachanis D] [Boussiotis V] [Kufe D] [Avigan D]
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand. Feb 2010 - :1440-1711 [PMID:20142835] [Petersen TR] [Sika-Paotonu D] [Knight DA] [Dickgreber N] [Farrand KJ] [Ronchese F] [Hermans IF]
Presentation of tumour antigens by dendritic cells and challenges faced. Feb 2010 - :1879-0372 [PMID:20116984] [Robson NC] [Hoves S] [Maraskovsky E] [Schnurr M]
Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus. Jan 2010 - :1476-5594 [PMID:20101224] [Puhlmann J] [Puehler F] [Mumberg D] [Boukamp P] [Beier R]
Dendritic Cells for Active Anti-cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification. Dec 2009 - ; 9(4):1871-5303 [PMID:19857199] [Breckpot K] [Escors D]
Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Dec 2009 - ; 15(24):1078-0432 [PMID:19996212] [Toh HC] [Wang WW] [Chia WK] [Kvistborg P] [Sun L] [Teo K] [Phoon YP] [Soe Y] [Tan SH] [Hee SW] [Foo KF] [Ong S] [Koo WH] [Zocca MB] [Claesson MH]
Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. Dec 2009 - Hum. Immunol.; 71(1):1879-1166 [PMID:19819280] [Holmstrøm K] [Pedersen AW] [Claesson MH] [Zocca MB] [Jensen SS]
Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors. Dec 2009 - Vaccine; 28(2):1873-2518 [PMID:19837091] [Kvistborg P] [Bechmann CM] [Pedersen AW] [Toh HC] [Claesson MH] [Zocca MB]
Dendritic cell vaccines for brain tumors. Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944973] [Kim W] [Liau LM]
Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Nov 2009 - Mol. Ther.; 17(12):1525-0024 [PMID:19773743] [Liu Q] [Zhai B] [Yang W] [Yu LX] [Dong W] [He YQ] [Chen L] [Tang L] [Lin Y] [Huang DD] [Wu HP] [Wu MC] [Yan HX] [Wang HY]
Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines. Nov 2009 - Methods Mol. Biol.; 595:1940-6029 [PMID:19941110] [Erdmann M] [Schuler-Thurner B]
A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer. Nov 2009 - Expert Opin Biol Ther; 9(12):1744-7682 [PMID:19916735] [Fishman M]
